MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.27) by 48.15 percent. This is a 8.11 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $23.32 million which beat the analyst consensus estimate of $21.48 million by 8.55 percent. This is a 20.50 percent increase over sales of $19.35 million the same period last year.